Skutella T - Search Results

1

Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats.

Skutella T, Probst JC, Engelmann M, Wotjak CT, Landgraf R, Jirikowski GF. Skutella T, et al. J Neuroendocrinol. 1994 Apr;6(2):121-5. doi: 10.1111/j.1365-2826.1994.tb00561.x. J Neuroendocrinol. 1994. PMID: 8049710

2

Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactation in rats.

Skutella T, Probst JC, Caldwell JD, Pedersen CA, Jirikowski GF. Skutella T, et al. Exp Clin Endocrinol Diabetes. 1995;103(3):191-5. doi: 10.1055/s-0029-1211349. Exp Clin Endocrinol Diabetes. 1995. PMID: 7584522

3

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats.

Skutella T, Montkowski A, Stöhr T, Probst JC, Landgraf R, Holsboer F, Jirikowski GF. Skutella T, et al. Cell Mol Neurobiol. 1994 Oct;14(5):579-88. doi: 10.1007/BF02088839. Cell Mol Neurobiol. 1994. PMID: 7621515

4

Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.

Skutella T, Stöhr T, Probst JC, Ramalho-Ortigao FJ, Holsboer F, Jirikowski GF. Skutella T, et al. Horm Metab Res. 1994 Oct;26(10):460-4. doi: 10.1055/s-2007-1001733. Horm Metab Res. 1994. PMID: 7851868

5

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat.

Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowski GF, Holsboer F. Skutella T, et al. Neuroreport. 1994 Oct 27;5(16):2181-5. doi: 10.1097/00001756-199410270-00048. Neuroreport. 1994. PMID: 7865772

6

Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats.

Skutella T, Probst JC, Engelmann M, Wotjak CT, Landgraf R, Jirikowski GF. Skutella T, et al. J Neuroendocrinol. 1994 Dec;6(6):626. doi: 10.1111/j.1365-2826.1994.tb00628.x. J Neuroendocrinol. 1994. PMID: 7894464 No abstract available.

7

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats.

Skutella T, Probst JC, Jirikowski GF, Holsboer F, Spanagel R. Skutella T, et al. Neurosci Lett. 1994 Feb 14;167(1-2):55-8. doi: 10.1016/0304-3940(94)91026-x. Neurosci Lett. 1994. PMID: 7909932

8

c-fos mRNA is present in axons of the hypothalamo-neurohypophysial system of the rat.

Skutella T, Probst JC, Jirikowski GF. Skutella T, et al. Cell Mol Biol (Noisy-le-grand). 1995 Sep;41(6):793-8. Cell Mol Biol (Noisy-le-grand). 1995. PMID: 8535172

9

Elevated messenger RNA levels after antisense oligodeoxynucleotide treatment in vitro and in vivo.

Probst JC, Skutella T. Probst JC, et al. Among authors: skutella t. Biochem Biophys Res Commun. 1996 Aug 23;225(3):861-8. doi: 10.1006/bbrc.1996.1264. Biochem Biophys Res Commun. 1996. PMID: 8780703

10

Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides.

Reul JM, Probst JC, Skutella T, Hirschmann M, Stec IS, Montkowski A, Landgraf R, Holsboer F. Reul JM, et al. Among authors: skutella t. Neuroendocrinology. 1997 Mar;65(3):189-99. doi: 10.1159/000127272. Neuroendocrinology. 1997. PMID: 9088000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters